Summary
62 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 15 years in a row and pays out only 46% of profit.
- It earns 14 USD a year on every 100 USD of invested capital.
- It bought back its own shares for $346.3M in the last fiscal year, 4.8% of its market value.
- Out of every 100 USD of revenue, 11 USD is left as free cash.
What to watch
- Revenue fell by 5.1% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 17.9 USD for 1 USD of yearly profit. Over the last five years it was 26.4 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.1% a year over 5 years. Over the last 3 years it fell by 5.1% a year. For the next fiscal year analysts expect revenue to grow by 3.3%. Earnings per share fell by 17% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 71 USD
- Sales and administration 19 USD
- Taxes and other 3.3 USD
- Net profit 7.3 USD
Net profit, industry median (Industrial - Distribution) 4.0 USD
Out of every 100 USD of revenue, 7.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.59%
- Paid out of profit
- 46%
- Raised in a row
- 15 years
You receive $5.10 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 11
- Hold 10
- Sell 1
Today's price within the analysts' price targets
The average target of $211.57 is 6.3% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
- UNITED STATES 93%
- Non-US 7.4%
Reportable Segment brings in 100% of revenue.
Segments in detail